Characterization of Monoclonal Antibodies to Calpain 3 and Protein Expression in Muscle from Patients with Limb-Girdle Muscular Dystrophy Type 2A
- 31 October 1998
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 153 (4) , 1169-1179
- https://doi.org/10.1016/s0002-9440(10)65661-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Calpain-3 Deficiency Causes a Mild Muscular Dystrophy in ChildhoodNeuropediatrics, 1997
- Early onset autosomal dominant myopathy with rigidity of the spine: a possible role for laminin β1?Neuromuscular Disorders, 1997
- Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophiesNeuromuscular Disorders, 1996
- The molecular biology of LGMD2B — Towards the identification of the LGMD gene on chromosome 2p13Neuromuscular Disorders, 1996
- Abnormalities in α-, β- and γ-sarcoglycan in patients with limb-girdle muscular dystrophyNeuromuscular Disorders, 1996
- Presence of long and short dystrophin and/or utrophin products in Torpedo marmorata peripheral nervesFEBS Letters, 1996
- Structure and physiological functions of ubiquitous and tissue-specific calpain species Muscle-specific calpain, p94, interacts with connectin/titinAdvances in Biophysics, 1996
- Muscle-specific Calpain, p94, Responsible for Limb Girdle Muscular Dystrophy Type 2A, Associates with Connectin through IS2, a p94-specific SequenceJournal of Biological Chemistry, 1995
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995
- Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyCell, 1994